News | December 02, 2023
Venus Remedies granted market authorizations in Saudi Arabia and Philippines
These regulatory approvals signify a significant milestone for Venus Remedies Limited
These regulatory approvals signify a significant milestone for Venus Remedies Limited
Profit after tax (before exceptional items) up 23% to Rs 215 crores
PFA technology is only marketed in Europe, and yet, it has been dominating the electrophysiology market by storm
Biocon will be responsible for obtaining regulatory approval for Liraglutide, and thereafter, for the manufacture and supply of the product in the Canadian market
The sale/transfer of the Company's API NonAntibiotic Business and API Antibiotic Business to Apitoria are complete
Biosergen AB is developing BSG005 for the treatment of severe and difficult-to-treat invasive fungal diseases
This is a strategic acquisition for Cipla South Africa to unlock the future growth opportunities in the South African market
BioNTech's diverse pipeline includes multiple drugs in Phase I, II, and III clinical trials
Senvelgo is the first liquid once-daily, orally administered prescription medication to improve glycemic control in cats with diabetes mellitus
Proposed acquisition represents meaningful step forward in Biogen’s strategy for sustainable growth
Subscribe To Our Newsletter & Stay Updated
